Dejaco C - Search Results

1

Tofacitinib in the treatment of ulcerative colitis : A position paper issued by the Inflammatory Bowel Disease Working Group of the Austrian Society of Gastroenterology and Hepatology (ÖGGH).

Kutschera M, Novacek G, Reinisch W, Högenauer C, Petritsch W, Haas T, Moschen A, Dejaco C. Kutschera M, et al. Among authors: dejaco c. Wien Klin Wochenschr. 2023 Jan;135(1-2):1-13. doi: 10.1007/s00508-022-02110-2. Epub 2022 Dec 1. Wien Klin Wochenschr. 2023. PMID: 36454302 Free PMC article.

2

Intravenous iron and erythropoietin for anemia associated with Crohn disease. A randomized, controlled trial.

Gasché C, Dejaco C, Waldhoer T, Tillinger W, Reinisch W, Fueger GF, Gangl A, Lochs H. Gasché C, et al. Among authors: dejaco c. Ann Intern Med. 1997 May 15;126(10):782-7. doi: 10.7326/0003-4819-126-10-199705150-00006. Ann Intern Med. 1997. PMID: 9148651 Clinical Trial.

3

Influence of topically and systemically active steroids on circulating leukocytes in Crohn's disease.

Tillinger W, Gasche C, Reinisch W, Lichtenberger C, Bakos S, Dejaco C, Moser G, Vogelsang H, Gangl A, Lochs H. Tillinger W, et al. Among authors: dejaco c. Am J Gastroenterol. 1998 Oct;93(10):1848-53. doi: 10.1111/j.1572-0241.1998.536_e.x. Am J Gastroenterol. 1998. PMID: 9772043 Clinical Trial.

4

[Cyclosporin A therapy in steroid-refractory patients with chronic inflammatory bowel diseases].

Dejaco C, Gasché C, Reinisch W, Moser G, Novacek G, Tillinger W, Vogelsang H, Gangl A. Dejaco C, et al. Wien Klin Wochenschr. 1998 Sep 4;110(16):579-84. Wien Klin Wochenschr. 1998. PMID: 9782579 German.

5

Poor diagnostic value of colonic CD44v6 expression and serum concentrations of its soluble form in the differentiation of ulcerative colitis from Crohn's disease.

Reinisch W, Heider KH, Oberhuber G, Dejaco C, Müllner M, Adolf GR, Gasché C. Reinisch W, et al. Among authors: dejaco c. Gut. 1998 Sep;43(3):375-82. doi: 10.1136/gut.43.3.375. Gut. 1998. PMID: 9863483 Free PMC article.

6

Stenosis of the common bile duct due to Ormond's disease: case report and review of the literature.

Dejaco C, Ferenci P, Schober E, Kaserer K, Függer R, Novacek G, Gangl A. Dejaco C, et al. J Hepatol. 1999 Jul;31(1):156-9. doi: 10.1016/s0168-8278(99)80176-7. J Hepatol. 1999. PMID: 10424296 Review.

7

IL-10 secretion and sensitivity in normal human intestine and inflammatory bowel disease.

Gasche C, Bakos S, Dejaco C, Tillinger W, Zakeri S, Reinisch W. Gasche C, et al. Among authors: dejaco c. J Clin Immunol. 2000 Sep;20(5):362-70. doi: 10.1023/a:1006672114184. J Clin Immunol. 2000. PMID: 11051278

8

In vivo effects of recombinant human interleukin-10 on lymphocyte phenotypes and leukocyte activation markers in inflammatory bowel disease.

Dejaco C, Reinisch W, Lichtenberger C, Waldhoer T, Kuhn I, Tilg H, Gasche C. Dejaco C, et al. J Investig Med. 2000 Nov;48(6):449-56. J Investig Med. 2000. PMID: 11094868 Clinical Trial.

9

Azathioprine treatment and male fertility in inflammatory bowel disease.

Dejaco C, Mittermaier C, Reinisch W, Gasche C, Waldhoer T, Strohmer H, Moser G. Dejaco C, et al. Gastroenterology. 2001 Nov;121(5):1048-53. doi: 10.1053/gast.2001.28692. Gastroenterology. 2001. PMID: 11677195

10

An open-label trial of the selective cyclo-oxygenase-2 inhibitor, rofecoxib, in inflammatory bowel disease-associated peripheral arthritis and arthralgia.

Reinisch W, Miehsler W, Dejaco C, Harrer M, Waldhoer T, Lichtenberger C, Vogelsang H. Reinisch W, et al. Among authors: dejaco c. Aliment Pharmacol Ther. 2003 Jun 1;17(11):1371-80. doi: 10.1046/j.1365-2036.2003.01596.x. Aliment Pharmacol Ther. 2003. PMID: 12786631 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

283 results

Search Page